This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A second discussion of the clinical landscape of IPF, with a focus on the use of OFEV and its potential expansion into the pediatric population.

Ticker(s): BOEHRINGER INGELHEIM

Who's the expert?

Institution: Community Healthcare Network

  • Board certified Pulmonary and Critical Care Physician
  • treats 18 patients with IPF
  • Is familiar and has read about PLN-74809

Interview Goal
Discussing the Idiopathic pulmonary fibrosis treatment landscape including current standard of care and FDA approved treatments. Looking at OFEV and its phase 3 trial for expansion into pediatric population

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.